NEW YORK (GenomeWeb News) — Celera said today it has closed its acquisition of Berkeley HeartLab for around $195 million in cash.
 
Celera said the acquisition, originally announced in early September, will begin to bring in accretive earnings in the second half of fiscal 2008.
  
Celera president Kathy Ordonez said the company was attracted to BHL for its existing products and for its potential to develop new predictive molecular diagnostics for cardiovascular disease.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.